BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 372624)

  • 1. [Platelet aggregation caused by ristocetin--its implication and action mechanism].
    Izuchi Y
    Nihon Rinsho; 1978 Dec; 36(12):3848-56. PubMed ID: 372624
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of frozen thrombocytes for the determination of von willebrand factor with the aid of ristocetin].
    Caduff T; Straub PW
    Schweiz Med Wochenschr; 1979 Mar; 109(11):399-402. PubMed ID: 34214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ristocetin in the diagnosis of von willebrand's disease: a comparison of rate and percent of aggregation with levels of the plasma factor(s) necessary for ristocetin aggregation.
    Dowling SV; Muntz RH; D'Souza S; Ekert H
    Thromb Diath Haemorrh; 1975 Nov; 34(2):465-74. PubMed ID: 1081746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-bound ristocetin aggregation factor in normal subjects and patients with von Willebrand's disease.
    Green D; Potter EV
    J Lab Clin Med; 1976 Jun; 87(6):976-86. PubMed ID: 778313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-type von Willebrand disease: results of a worldwide survey from the Canadian PT-VWD project.
    Othman M; Hamilton A
    Acta Haematol; 2010; 123(2):126-8. PubMed ID: 20090310
    [No Abstract]   [Full Text] [Related]  

  • 6. Platelet refractoriness to classical agonists in a child with essential thrombocythemia.
    Jaime-Perez JC; Gomez-Almaguer D
    Platelets; 2005 Feb; 16(1):61-2. PubMed ID: 15763898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired ristocetin aggregation in myeloma due to binding of the aggregating agent by monoclonal protein--presentation of a case.
    László E; Péterfy M; Puskás E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(6):852-6. PubMed ID: 2453415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the mechanism of ristocetin-induced platelet agglutination: binding of ristocetin to platelets.
    Jenkins CS; Clemetson KJ; Lüscher EF
    J Lab Clin Med; 1979 Feb; 93(2):220-31. PubMed ID: 311800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rapid, automated VWF ristocetin cofactor activity assay improves reliability in the diagnosis of Von Willebrand disease.
    Bowyer AE; Shepherd F; Kitchen S; Makris M
    Thromb Res; 2011 Apr; 127(4):341-4. PubMed ID: 21186048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Platelet dysfunction in patients with essential thrombocythemia--acquired von Willebrand's disease].
    Mohri H; Asada H; Kodama F; Itoh A; Ohkubo T
    Nihon Ketsueki Gakkai Zasshi; 1986 Nov; 49(7):1418-26. PubMed ID: 3493613
    [No Abstract]   [Full Text] [Related]  

  • 11. [Participation of von Willebrand factor in blood platelet functions].
    Mikami S; Takahashi Y; Nishino M; Fukui H
    Nihon Rinsho; 1978 Dec; 36(12):3824-9. PubMed ID: 372620
    [No Abstract]   [Full Text] [Related]  

  • 12. Prospective study of low-dose ristocetin-induced platelet aggregation to identify type 2B von Willebrand disease (VWD) and platelet-type VWD in children.
    Frontroth JP; Hepner M; Sciuccati G; Feliú Torres A; Pieroni G; Bonduel M
    Thromb Haemost; 2010 Dec; 104(6):1158-65. PubMed ID: 20941465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [von Willebrand's disease with an increased ristocetin-induced platelet aggregation and a qualitative abnormality of the factor VIII protein (author's transl)].
    Takahashi H; Oda E; Hattori A; Kobayashi I; Takahashi K; Sakuragawa N; Shibata A
    Rinsho Ketsueki; 1980 Apr; 21(4):544-54. PubMed ID: 6774131
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of ristocetin-induced platelet agglutination by vancomycin.
    Moake JL; Cimo PL; Peterson DM; Roper P; Natelson EA
    Blood; 1977 Sep; 50(3):397-406. PubMed ID: 301760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agglutination of formalin-fixed, platelet-type von Willebrand's disease platelets by human von Willebrand factor.
    Takahashi H; Shibata A
    Thromb Haemost; 1984 Dec; 52(3):267-70. PubMed ID: 6241752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Family studies of patients with reduced ristocetin aggregation and abnormalities of factor VIII and/or platelet function.
    Ekert H; Ananthakrishnan R; Muntz RH; Dowling S; D'Souza S
    Thromb Haemost; 1976 Aug; 36(1):78-85. PubMed ID: 1087478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Simple rapid test for assaying ristocetin cofactor].
    Aznar JA; Borrego D; Martín G; Jorquera J; Jiménez C; García I; Marty ML
    Sangre (Barc); 1982; 27(5):959-66. PubMed ID: 6984787
    [No Abstract]   [Full Text] [Related]  

  • 18. [Blood platelet disorders. I. Genetically determined syndrome].
    Michalski R; Pniejnia-Olszyński W
    Acta Haematol Pol; 1977; 8(1):49-55. PubMed ID: 322436
    [No Abstract]   [Full Text] [Related]  

  • 19. [Ristocetin-induced platelet aggregation in von Willebrand's disease, thrombasthenia and essential athrombia with special reference to AHF-like antigen (author's transl)].
    Ishiguro J; Kondo M; Ogata K; Takahashi T; Kamiya T
    Rinsho Ketsueki; 1975 Jul; 16(7):716-24. PubMed ID: 1080812
    [No Abstract]   [Full Text] [Related]  

  • 20. Platelets fixed with paraformaldehyde: a new reagent for assay of von Willebrand factor and platelet aggregating factor.
    Allain JP; Cooper HA; Wagner RH; Brinkhous KM
    J Lab Clin Med; 1975 Feb; 85(2):318-28. PubMed ID: 234499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.